Benjamin Morgan Scirica MD
Brigham and Women's Hospital Associate Professor of Medicine, Harvard Medical School
Join to View Full Profile
75 Francis StBrigham And Women's HospitalBoston, MA 02115
Phone+1 857-307-4000
Dr. Scirica is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Benjamin Scirica is a cardiologist in Boston, MA and is affiliated with Brigham and Women's Hospital. He received his medical degree from Harvard Medical School and has been in practice 18 years. He also speaks multiple languages, including Spanish. He is experienced in general cardiology and cardiac critical care.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Cardiovascular Disease, 2002 - 2005
Harvard School of Public HeathMPH, 2005- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1999 - 2002
Harvard Medical SchoolClass of 1999
Certifications & Licensure
MA State Medical License 2001 - 2026
NH State Medical License 2023 - 2025
FL State Medical License 2022 - 2024
ME State Medical License 2022 - 2024
RI State Medical License 2022 - 2024
VT State Medical License 2023 - 2024
CT State Medical License 2022 - 2023
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FESC) European Society of Cardiology, 2014
- Fellow (FAHA) American Heart Association, 2012
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- A Polygenic Risk Score to Predict Incident Heart Failure Across the Spectrum of Cardiovascular Risk.Paul M Haller, Giorgio E M Melloni, David D Berg, Frederick K Kamanu, Yi-Pin Lai
Journal of the American College of Cardiology. 2025-09-23 - Pathogenic Cardiomyopathy-Associated Gene Variants and Prognosis in Atrial Fibrillation: Results in 18,000 Clinical Trial Participants.Sean J Jurgens, Giorgio E M Melloni, Shinwan Kany, Larissa Fabritz, Joel T Rämö
Journal of the American College of Cardiology. 2025-09-09 - Glucagon-like peptide-1 receptor agonists lower risk of cardiovascular and non-cardiovascular mortality: A meta-analysis of eleven cardiovascular outcome trials.Yu Mi Kang, Erin A Bohula, A Michael Lincoff, Donna H Ryan, KyungAh Im
Diabetes, Obesity & Metabolism. 2025-07-01
Journal Articles
- Remote Optimization of Guideline-Directed Medical Therapy in Patients with Heart Failure with Reduced Ejection FractionAkshay S Desai, Thomas Gaziano, Benjamin Scirica, Calum A Macrae, JAMA Cardiology
- Cardiovascular Safety of Lorcaserin in Overweight or Obese PatientsErin A Bohula, Stephen D Wiviott, Benjamin M Scirica, Darren K McGuire, Marc S Sabatine, Marc P Bonaca, Christian T Ruff, Silvio E Inzucchi, The New England Journal of Medicine
- Navigator-Driven Remote Optimization of Guideline-Directed Medical Therapy in Patients with Heart Failure with Reduced Ejection Fraction: Program Design and Initial Fe...Thomas A Gaziano, Calum A Macrae, Benjamin M Scirica, Akshay S Desai, Journal of Cardiac Failure
Authored Content
- Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients with Type 2 Diabetes at High Cardiovascular RiskDecember 2017
- 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsMarch 2017
Press Mentions
How Technological Innovations Could Improve CVD Risk Factor ManagementSeptember 26th, 2024- Wegovy May Reduce the Risk of Death from COVID-19, Study SuggestsSeptember 13th, 2024
- Weight-Loss Drugs Could Reduce COVID-Related Deaths: StudySeptember 4th, 2024
- Join now to see all
Professional Memberships
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
